Organ procurement teams are leery of accepting kidneys from deceased donors with acute kidney injury (AKI) fearing they will harm the recipients. However, a national study chaired by a Johns Hopkins kidney specialist suggests these fears may be unfounded.
Alan Partin, M.D., Ph.D., and his research group develop and test blood, urine and tissue cells to detect prostate cancer early.
Urologist, Phillip Pierorazio, MD, reviews the management options for early-stage testicular cancer, with a focus on retroperitoneal lymph node dissection (RPLND) - he also looks at the incidence of testicular cancer in the US and surivival rates.
#TomorrowsDiscoveries: Dr. DeWeese and his team are testing a way to target a protein found on the surface of cancer cells, but not non-cancer cells. Their goal is to destroy cancer while protecting normal tissue.
Urologic oncologist Kenneth Pienta and his team are working to identify what keeps disseminated tumor cells asleep or reactivates them so that they can better treat prostate cancer.
Featured Articles View All »